5 from QS/1: Highlights in Pharmacy News – May 2019

Check out 4 developments in our field that are worth knowing about – and 1 extra, just because.

  1. FDA Patient Education Campaign Targets Opioid Diversion, Disposal

The FDA has launched a public awareness program called Remove the Risk. The agency contends that “if every household removed prescription opioids once they’re no longer medically needed… it would have a major impact on the opioid crisis.”

  1. FTC Charges Surescripts with Illegal Monopolization of E-Prescription Markets

The federal agency is suing the company for anticompetitive restraints that monopolize routing and eligibility services in the electronic prescribing market.

  1. NCPA, NACDS Statement on Drug Pricing Rule’s Failure to Reform Pharmacy DIR

After a final drug pricing rule failed to reform DIR fees, the National Community Pharmacists Association and the National Association of Chain Drug Stores expressed disappointment and frustration, warning  of the unsustainable situation faced by pharmacies.

  1. USP Compounding Updates Nearing Publication, Implementation

Chapters that contain revised standards for sterile and non-sterile compounding, as well as for radiopharmaceuticals, will be published June 1 for implementation by December 1.

Just because…
5. Facebook Takes Steps to Reduce Vaccine Misinformation

The company announced that groups or pages that post inaccurate information about vaccines will see their rankings reduced in the news feed and search results.

Share this Post

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

About QS/1

QS/1 is the leader in pharmacy management systems, providing software for community pharmacies in an ever-changing and dynamic healthcare marketplace. We are, and have always been, customer focused, and our software solutions help independent, chain, hospital outpatient pharmacies, and HME businesses remain relevant, profitable, and proficient through technology. QS/1 is the only vendor with an integrated suite of products and services, including POS, IVR, document management, mobile and delivery apps, prescription synchronization, and HME billing and compliance. We also offer the industry’s only 24/7 Emergency Customer Support. QS/1 is part of Smith Technologies, LLC, a subsidiary of the J M Smith Corporation, one of the largest privately held companies in South Carolina.

Legal | HIPAA | Careers | Sitemap

Contact Us

© 2019 J M Smith Corporation. QS/1, the QS/1 logo, NRx, SharpRx, ShipRx, SystemOne, CornerDrugstore, Health-Minder, InstantFill, mobileRx, PaySentry, QS/1 DeliveryRx, QDM, Remote Checkout, and RetrieveRx are registered trademarks and Multi-Site Management is a trademark of the J M Smith Corporation. QS/1 is part of Smith Technologies®, LLC, a subsidiary of the J M Smith Corporation.